ENTRY       D03245                      Drug
NAME        Nartograstim (genetical recombination) (JP18);
            Nartograstim (INN)
FORMULA     C850H1344N226O245S8
EXACT_MASS  18893.7422
MOL_WEIGHT  18905.6536
SEQUENCE    MAPTYRASSL PQSFLLKSLE QVRKIQGDGA ALQEKLCATY KLCHPEELVL LGHSLGIPWA
            PLSSCPSQAL QLAGCLSQLH SGLFLYQGLL QALEGISPEL GPTLDTLQLD VADFATTIWQ
            QMEELGMAPA LQPTQGAMPA FASAFQRRAG GVLVASHLQS FLEVSYRVLR HLAQP
            (Disulfide bridge: 37-43, 65-75)
  TYPE      Peptide
CLASS       Immunological agent
             DG01753  Colony stimulating factor
              DG01781  Granulocyte colony stimulating factor (G-CSF)
EFFICACY    Antineutropenic, Hematopoietic stimulant, Granulocyte colony stimulating factor (G-CSF)
COMMENT     recombinant Granulocyte colony stimulating factor (G-CSF) [HSA:1440] [KO:K05423]
TARGET      CSF3R (GCSFR, CD114) [HSA:1441] [KO:K05061]
  PATHWAY   hsa04060(1441)  Cytokine-cytokine receptor interaction
            hsa04630(1441)  JAK-STAT signaling pathway
BRITE       Drug groups [BR:br08330]
             Immunological agent
              DG01753  Colony stimulating factor
               DG01781  Granulocyte colony stimulating factor (G-CSF)
                D03245  Nartograstim
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                CSF3R (GCSFR, CD114)
                 D03245  Nartograstim (genetical recombination) (JP18)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D03245  Nartograstim (genetical recombination)
              D03245  Nartograstim for injection (genetical recombination)
DBLINKS     CAS: 134088-74-7
            PubChem: 17397398
            NIKKAJI: J375.122H
///
